Global Calcium Antagonists Market Growth 2023-2029

Global Calcium Antagonists Market Growth 2023-2029

Calcium antagonists are a group of medications that disrupt the movement of calcium (Ca2+) through calcium channels. Calcium channel blockers are used as antihypertensive drugs, i.e., as medications to decrease blood pressure in patients with hypertension. CCBs are particularly effective against large vessel stiffness, one of the common causes of elevated systolic blood pressure in elderly patients. Calcium channel blockers are also frequently used to alter heart rate (especially from atrial fibrillation), to prevent peripheral and cerebral vasospasm, and to reduce chest pain caused by angina pectoris.

N-type, L-type, and T-type voltage-dependent calcium channels are present in the zona glomerulosa of the human adrenal gland, and CCBs can directly influence the biosynthesis of aldosterone in adrenocortical cells, with consequent impact on the clinical treatment of hypertension with these agents.

CCBs have been shown to be slightly more effective than beta blockers at lowering cardiovascular mortality, but they are associated with more side effects. Potential major risks however were mainly found to be associated with short-acting CCBs.

LPI (LP Information)' newest research report, the “Calcium Antagonists Industry Forecast” looks at past sales and reviews total world Calcium Antagonists sales in 2022, providing a comprehensive analysis by region and market sector of projected Calcium Antagonists sales for 2023 through 2029. With Calcium Antagonists sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Calcium Antagonists industry.

This Insight Report provides a comprehensive analysis of the global Calcium Antagonists landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Calcium Antagonists portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Calcium Antagonists market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Calcium Antagonists and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Calcium Antagonists.

The global Calcium Antagonists market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Calcium Antagonists is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Calcium Antagonists is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Calcium Antagonists is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Calcium Antagonists players cover Pfizer, Aventis, Searle, Bayer, AstraZeneca, Knoll Pharmaceuticals, Wyeth-Ayerst, Novartis and Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Calcium Antagonists market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Dihydropyridine
Diltiazem
Verapamil
Others

Segmentation by application
Hypertension
Coronary Artery Disease
Arrhythmia
Ohers

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Aventis
Searle
Bayer
AstraZeneca
Knoll Pharmaceuticals
Wyeth-Ayerst
Novartis
Sanofi
Baiyunshan Pharmaceutical
South China Pharmaceutical Group
Tianjin Tanabe Seiyaku

Key Questions Addressed in this Report

What is the 10-year outlook for the global Calcium Antagonists market?

What factors are driving Calcium Antagonists market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Calcium Antagonists market opportunities vary by end market size?

How does Calcium Antagonists break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.